Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CF STORM
ISRCTN14081521Phase 4Completed
- Sponsor
- Alder Hey Children's NHS Foundation Trust
- Start
- Jul 2021
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
01
Overview
Phase 4, randomised, open-label trial of elexacaftor, dornase alfa and hypertonic saline in cystic fibrosis (CF) (2 arms), sponsored by Alder Hey Children's NHS Foundation Trust. Started Jul 2021; status: completed.
02
Drugs
elexacaftordornase alfahypertonic saline
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on ISRCTN14081521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN14081521.